1-3 of 3
Joelle Guilhot, Ph.D.
Close
Sort by
Journal Articles

Imatinib Has a Negative Impact On Growth In Children With Previously Untreated Chronic Myeloid Leukaemia (CML) In Early Chronic Phase (CP): Results Of The French National Study

Frédéric Millot, Joelle Guilhot, Ph.D., Andre Baruchel, MD, PhD, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yacouben, Pascal Chastagner, Virginie Gandemer, MD, PhD, Yves Reguerre, Gérard Couillaud, Jean-Michel Cayuela
Journal: Blood
Blood (2013) 122 (21): 4001.
https://doi.org/10.1182/blood.V122.21.4001.4001
Published: 2013
Journal Articles

Low Natural Killer (NK) Cell Counts and Functionality Are Associated With Molecular Relapse After Imatinib Discontinuation In Patients (pts) With Chronic Phase (CP)-Chronic Myeloid Leukemia (CML) With Undetectable BCR-ABL Transcripts For At Least 2 Years: Preliminary Results From Immunostim, On Behalf Of STIM Investigators

Delphine Rea, MD, PhD, Nicolas Dulphy, PhD, Guylaine Henry, Ing., Joelle Guilhot, Ph.D., Francois Guilhot, PhD, Franck E. Nicolini, MD PhD, Laurence Legros, MD, PhD, Philippe Rousselot, MD, PhD, Francois-Xavier Mahon, Antoine Toubert
Journal: Blood
Blood (2013) 122 (21): 856.
https://doi.org/10.1182/blood.V122.21.856.856
Published: 2013
Journal Articles

The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): Objectives and Preliminary Results

Frédéric Millot, Meinolf Suttorp, MD, Joelle Guilhot, Ph.D., Pietr Sedlacek, Evelina S De Bont, Chi Kong Li, MBBS, MD, Krzysztof Kalwak, Birgitte Lausen, Culic Srdjana, Marie-Françoise Dresse, Andrea Biondi, MD, André Baruchel
Journal: Blood
Blood (2012) 120 (21): 3741.
https://doi.org/10.1182/blood.V120.21.3741.3741
Published: 2012